Alejandro Pérez Cabeza

1.3k total citations
37 papers, 234 citations indexed

About

Alejandro Pérez Cabeza is a scholar working on Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging and Internal Medicine. According to data from OpenAlex, Alejandro Pérez Cabeza has authored 37 papers receiving a total of 234 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Cardiology and Cardiovascular Medicine, 7 papers in Radiology, Nuclear Medicine and Imaging and 5 papers in Internal Medicine. Recurrent topics in Alejandro Pérez Cabeza's work include Atrial Fibrillation Management and Outcomes (24 papers), Cardiac Arrhythmias and Treatments (19 papers) and Cardiac Imaging and Diagnostics (7 papers). Alejandro Pérez Cabeza is often cited by papers focused on Atrial Fibrillation Management and Outcomes (24 papers), Cardiac Arrhythmias and Treatments (19 papers) and Cardiac Imaging and Diagnostics (7 papers). Alejandro Pérez Cabeza collaborates with scholars based in Spain, United Kingdom and Denmark. Alejandro Pérez Cabeza's co-authors include Julio Martí‐Almor, María José Martínez‐Zapata, Carlos Escobar, Carlos Escobar, Eduardo de Teresa Galván, Juan José Gómez‐Doblas, Isabel Rodríguez Bailón, Román Freixa‐Pamias, Jaime Díaz‐Guzmán and José Antonio González Correa and has published in prestigious journals such as Journal of the American College of Cardiology, PLoS ONE and European Heart Journal.

In The Last Decade

Alejandro Pérez Cabeza

33 papers receiving 228 citations

Peers

Alejandro Pérez Cabeza
Šime Manola Croatia
Mary L. Chandler United States
Anja Katholing Australia
Raphael Diaz Argentina
Byung Chun Jung South Korea
Gerd Bürkle Germany
Šime Manola Croatia
Alejandro Pérez Cabeza
Citations per year, relative to Alejandro Pérez Cabeza Alejandro Pérez Cabeza (= 1×) peers Šime Manola

Countries citing papers authored by Alejandro Pérez Cabeza

Since Specialization
Citations

This map shows the geographic impact of Alejandro Pérez Cabeza's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Pérez Cabeza with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Pérez Cabeza more than expected).

Fields of papers citing papers by Alejandro Pérez Cabeza

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Pérez Cabeza. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Pérez Cabeza. The network helps show where Alejandro Pérez Cabeza may publish in the future.

Co-authorship network of co-authors of Alejandro Pérez Cabeza

This figure shows the co-authorship network connecting the top 25 collaborators of Alejandro Pérez Cabeza. A scholar is included among the top collaborators of Alejandro Pérez Cabeza based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alejandro Pérez Cabeza. Alejandro Pérez Cabeza is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Rivera‐Caravaca, José Miguel, Manuel Anguita Sánchez, Marcelo Sanmartı́n, et al.. (2023). Adverse Clinical Outcomes and Associated Predictors in Rivaroxaban-Treated Atrial Fibrillation Patients With Renal Impairment. The American Journal of Cardiology. 203. 122–127. 2 indexed citations
3.
Ortiz, Martín Ruiz, et al.. (2023). Clinical outcomes and mortality in patients with atrial fibrillation and recently diagnosed lung cancer in oncology outpatient settings. Current Problems in Cardiology. 49(2). 102239–102239. 4 indexed citations
4.
Escobar, Carlos, Julio Martí‐Almor, Alejandro Pérez Cabeza, et al.. (2022). Real-world cost-effectiveness analysis of NOACs versus VKA for stroke prevention in Spain. PLoS ONE. 17(4). e0266658–e0266658. 9 indexed citations
5.
Sanmartı́n, Marcelo, Manuel Anguita Sánchez, Fernando Arribas, et al.. (2022). Outcomes and predictive value of the 2MACE score in patients with atrial fibrillation treated with rivaroxaban in a prospective, multicenter observational study: The EMIR study. Cardiology Journal. 29(4). 601–609. 3 indexed citations
6.
Sánchez, Manuel Anguita, Francisco Marı́n, Jaime Masjuán, et al.. (2022). Impact of heart failure on the clinical profile and outcomes in patients with atrial fibrillation treated with rivaroxaban. Data from the EMIR study. Cardiology Journal. 29(6). 936–947. 1 indexed citations
7.
Masjuán, Jaime, Ángel Cequier, Carmen Suárez Fernández, et al.. (2021). Prevención del ictus en pacientes con fibrilación auricular. Mejorar la protección enla era de la COVID-19. Revista Española de Cardiología Suplementos. 21. 9–17. 1 indexed citations
9.
Anguita, Manuel, Mariano de la Figuera, Alejandro Pérez Cabeza, & Carmen Suárez Fernández. (2019). Clinical profile and management of rivaroxaban in patients with atrial fibrillation in routine practice in Spain: data from six nationwide studies. Drugs in Context. 8. 1–11.
10.
Cabeza, Alejandro Pérez, et al.. (2018). TIMI‐AF score and cardiovascular events in vitamin K antagonists‐naïve outpatients with atrial fibrillation. Clinical Cardiology. 41(9). 1252–1258. 3 indexed citations
11.
Escobar, Carlos, Julio Martí‐Almor, Alejandro Pérez Cabeza, & María José Martínez‐Zapata. (2018). Direct Oral Anticoagulants Versus Vitamin K Antagonists in Real-life Patients With Atrial Fibrillation. A Systematic Review and Meta-analysis. Revista Española de Cardiología (English Edition). 72(4). 305–316. 25 indexed citations
14.
Gómez‐Iturriaga, Alfonso, Alejandro Pérez Cabeza, Josep Jové, et al.. (2016). The number of risk factors is the strongest predictor of prostate cancer mortality: multi-institutional outcomes of an extreme-risk prostate cancer cohort. Clinical & Translational Oncology. 18(10). 1026–1033. 3 indexed citations
15.
Cabeza, Alejandro Pérez, et al.. (2015). PARADOXICAL LOW FLOW-LOW GRADIENT SEVERE AORTIC STENOSIS: A CLINICAL ENTITY OR A SCIENTIFIC ARTIFACT. Journal of the American College of Cardiology. 65(10). A1981–A1981. 1 indexed citations
16.
Jiménez‐Navarro, Manuel F., Lourdes Garrido‐Sánchez, Juan H. Alonso‐Briales, et al.. (2014). Newly impaired glucose metabolism and prognosis after percutaneous revascularization. Cardiology Journal. 22(1). 44–51. 3 indexed citations
17.
Cabeza, Alejandro Pérez, et al.. (2006). Tomografía computarizada con multidetectores de venas coronarias y terapia de resincronización. Revista Española de Cardiología. 59(10). 1070–1070. 2 indexed citations
18.
Cabeza, Alejandro Pérez, et al.. (2005). Disfunción ventricular sistólica, un nuevo marcador de enfermedad coronaria en pacientes con estenosis aórtica sin infarto de miocardio previo. Revista Española de Cardiología. 58(2). 218–221. 2 indexed citations
19.
Bailón, Isabel Rodríguez, et al.. (2004). Obstrucción dinámica intraventricular izquierda inducida por esfuerzo. Revista Española de Cardiología. 57(12). 1179–1187. 19 indexed citations
20.
Cabeza, Alejandro Pérez, et al.. (1976). Changes in serum and cerebrospinal fluid enzyme activity after head injury. Acta Neurochirurgica. 35(1-3). 3–13. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026